Shareholdings
| Concept |
2023-04-01 to 2024-03-31 |
As at 2024-03-31 |
|---|---|---|
| Shareholdings | ||
| Reporting company | ||
| Investment shares held for purposes other than pure investment | ||
| Shares not listed | ||
| Number of issues | — |
37
xbrli:pure
|
| Carrying amount | — |
10,654,000,000
JPY
|
| Number of issues whose number of shares increased |
8
xbrli:pure
|
— |
| Total acquisition cost for increased shares |
4,720,000,000
JPY
|
— |
| Reason for increase in number of shares |
・医薬品事業及びエコシステム戦略における、関係性の強化、協業の推進のため
|
— |
| Number of issues whose number of shares decreased |
2
xbrli:pure
|
— |
| Total sale amount for decreased shares |
2,000,000
JPY
|
— |
| Shares other than those not listed | ||
| Number of issues | — |
7
xbrli:pure
|
| Carrying amount | — |
23,571,000,000
JPY
|
| Number of issues whose number of shares increased |
1
xbrli:pure
|
— |
| Total acquisition cost for increased shares |
5,000,000
JPY
|
— |
| Reason for increase in number of shares |
・一層の取引強化のため
・医薬品事業戦略における関係の維持・強化のため
|
— |
| Number of issues whose number of shares decreased |
4
xbrli:pure
|
— |
| Total sale amount for decreased shares |
3,477,000,000
JPY
|
— |